0000000001308554

AUTHOR

F. Bonnet

showing 6 related works from this author

Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

2021

BACKGROUND: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduces risk for AIDS and non-AIDS-related events in asymptomatic, HIV-positive persons and is the standard of care. However, most HIV-positive persons initiate ART when their CD4 count decreases below 500 × 10 9 cells/L. Consequences of delayed ART on risk for non-AIDS-defining and AIDS-defining cancer, one of the most common reasons for death in HIV, are unclear. OBJECTIVE: To estimate the long-term risk difference for cancer with the immediate ART strategy.DESIGN: Multinational prospective cohort study.SETTING: The D:A:D (Data collection on Adverse events of anti-HIV Drugs) study, which included…

MaleHIV AIDSHIV Infections0302 clinical medicineInterquartile rangeRisk FactorsNeoplasmsMedicine030212 general & internal medicineProspective StudiesProspective cohort study0303 health sciencesIncidenceAbsolute risk reductionDrugsGeneral MedicineMiddle AgedViral LoadAntiretroviral therapy3. Good healthAIDSCancer treatmentPrevention policy and public healthCohortInfectious diseasesCohort studiesFemaleViral loadAdultmedicine.medical_specialtyAnti-HIV AgentsHIV Infections/drug therapySocio-culturaleTime-to-Treatment03 medical and health sciencesAcquired immunodeficiency syndrome (AIDS)SDG 3 - Good Health and Well-beingInternal medicineInternal MedicineHumansAdverse effect030306 microbiologybusiness.industryHIVCancermedicine.diseaseCD4 Lymphocyte CountCancer.Anti-HIV Agents/therapeutic use[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessNeoplasms/epidemiologyAnnals of Internal Medicine
researchProduct

CCDC 244818: Experimental Crystal Structure Determination

2004

Related Article: F.Bonnet, M.Visseaux, D.Barbier-Baudry, A.Hafid, E.Vigier, M.M.Kubicki|2004|Inorg.Chem.|43|3682|doi:10.1021/ic035444l

Space GroupCrystallographydodecakis(mu~2~-Tetrahydroborato)-hexakis(eta^5^-tetramethyl-n-propyl-cyclopentadienyl)-tetra-neodymiumCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 244819: Experimental Crystal Structure Determination

2004

Related Article: F.Bonnet, M.Visseaux, D.Barbier-Baudry, A.Hafid, E.Vigier, M.M.Kubicki|2004|Inorg.Chem.|43|3682|doi:10.1021/ic035444l

Space GroupCrystallographyCrystal SystemCrystal Structuretetrakis(mu~3~-Chloro)-bis(mu~2~-tetrahydroborato)-hexakis(mu~2~-chloro)-hexakis(eta^5^-tetramethyl-n-propyl-cyclopentadienyl)-bis(tetrahydrofuran)-hexa-samariumCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 244817: Experimental Crystal Structure Determination

2004

Related Article: F.Bonnet, M.Visseaux, D.Barbier-Baudry, A.Hafid, E.Vigier, M.M.Kubicki|2004|Inorg.Chem.|43|3682|doi:10.1021/ic035444l

Space GroupCrystallographyCrystal SystemCrystal Structuredodecakis(mu~2~-Tetrahydroborato)-hexakis(eta^5^-tetramethyl-n-propyl-cyclopentadienyl)-tetra-samariumCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 244821: Experimental Crystal Structure Determination

2004

Related Article: F.Bonnet, M.Visseaux, D.Barbier-Baudry, A.Hafid, E.Vigier, M.M.Kubicki|2004|Inorg.Chem.|43|3682|doi:10.1021/ic035444l

Space GroupCrystallographyCrystal SystemCrystal Structuredodecakis(mu~2~-Tetrahydroborato)-hexakis(eta^5^-tetramethyl-n-propyl-cyclopentadienyl)-tetra-samarium tetrakis(mu~3~-chloro)-bis(mu~2~-tetrahydroborato)-hexakis(mu~2~-chloro)-hexakis(eta^5^-tetramethyl-n-propyl-cyclopentadienyl)-bis(tetrahydrofuran)-hexa-samarium pentane solvateCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 244820: Experimental Crystal Structure Determination

2004

Related Article: F.Bonnet, M.Visseaux, D.Barbier-Baudry, A.Hafid, E.Vigier, M.M.Kubicki|2004|Inorg.Chem.|43|3682|doi:10.1021/ic035444l

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameterstetrakis(mu~3~-Chloro)-bis(mu~2~-tetrahydroborato)-hexakis(mu~2~-chloro)-hexakis(eta^5^-tetramethyl-n-propyl-cyclopentadienyl)-bis(tetrahydrofuran)-hexa-neodymiumExperimental 3D Coordinates
researchProduct